Condition
Chronic Kidney Disease Stage 3 and 4
Total Trials
5
Recruiting
3
Active
3
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
60%
3 trials in Phase 3/4
Results Transparency
200%
2 of 1 completed with results
Key Signals
2 with results50% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 3 (3)
Trial Status
Recruiting3
Terminated1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06858280Phase 3Recruiting
Patiromer and Diet/hrQoL in Chronic Dialysis
NCT06621264Not ApplicableRecruitingPrimary
Exercise Activity to Improve Mobility in Patients With CKD and PAD
NCT06933108RecruitingPrimary
Prediction of Peripheral Neuropathy With Functional Testing
NCT01020487Phase 3CompletedPrimary
Safety and Efficacy of Paricalcitol Capsules in Decreasing Serum Parathyroid Hormone Levels in Children Aged 10-16 With Chronic Kidney Disease (CKD)
NCT01173848Phase 3TerminatedPrimary
Vitamin D Supplement Study for Stage Three and Four Chronic Kidney Disease (CKD) Patients
Showing all 5 trials